Mirae Asset Global ETFs Holdings’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$296K	Buy	8,737 +1,023	+13%	+$34.1K	﹤0.01%	2292
2026 Q1	$232K	Buy	7,714 +990	+15%	+$31.9K	﹤0.01%	2284
2025 Q4	$210K	Buy	6,724 +414	+7%	+$10.2K	﹤0.01%	2335
2025 Q3	$127K	Buy	6,310 +856	+16%	+$15K	﹤0.01%	2559
2025 Q2	$91.4K	Buy	5,454 +430	+9%	+$6.94K	﹤0.01%	2653
2025 Q1	$77.2K	Sell	5,024 -5,024	-50%	-$89.7K	﹤0.01%	2736
2024 Q4	$221K	Buy	10,048 +5,526	+122%	+$101K	﹤0.01%	2346
2024 Q3	$81.5K	Buy	+4,522	New	+$79.1K	﹤0.01%	2790

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's TEVA Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 13% in Q2 2026, buying an estimated $34.1K and bringing the position to 8,737 shares worth $296K. The position accounts for ﹤0.01% of the portfolio, ranked #2292.

Mirae Asset Global ETFs Holdings first reported a position in TEVA in Q3 2024 and has held it in 8 quarters since. 677 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Mirae Asset Global ETFs Holdings held 8,737 shares of Teva Pharmaceutical Industries Limited worth $296K as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 1,023 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $34.1K.
Teva Pharmaceutical Industries Limited made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2292 holding.
Mirae Asset Global ETFs Holdings first reported a position in Teva Pharmaceutical Industries Limited in Q3 2024 and has held it in 8 quarters since.
677 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.